You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The service is the first of its kind in the UK and relies on the Illumina NovaSeq 6000 platform to deliver results.
Sequencing and other analyses helped uncover a JAK1 variant within a patient with an unknown autoimmune disorder disease and find a treatment approach.
The expansions were often in exons or near splice junctions of genes involved in nervous system development, the cardiovascular system, and muscle tissue.
Most of the disease risk carriers identified in the Healthy Nevada Project did not meet clinical guidelines for screening, according to the new analysis.
BostonGene will analyze the tumors of patients enrolled in NEC or NEC-affiliated clinical trials and NEC will use the data to help improve treatment responses.